Most of those two weeks is not science. It is finding and assembling the data, which is also where most of the AI sold to pharma quietly stalls.
研究与报告2026年8月30日•1 分钟阅读
AI in Pharma Faces Data‑Gathering Delays, Not Scientific Limits
A recent note says most of the two‑week deviation investigation time is spent on data collection, not science, highlighting a bottleneck for AI tools in pharma.
由 PharmaCountry 团队整理 · 来源： FiercePharma
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分